Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review of Chitosan-Based Nanocarriers As Drug Delivery Systems for Brain Diseases: Critical Challenges, Outlooks and Promises Publisher Pubmed



Khodaverdi K1 ; Bakhshi A1, 2, 3 ; Mozafari MR2 ; Naghib SM1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, 1684613114, Iran
  2. 2. Australasian Nanoscience and Nanotechnology Initiative (ANNI), Monash University LPO, Clayton, 3168, VIC, Australia
  3. 3. Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Source: International Journal of Biological Macromolecules Published:2024


Abstract

The administration of medicinal drugs orally or systemically limits the treatment of specific central nervous system (CNS) illnesses, such as certain types of brain cancers. These methods can lead to severe adverse reactions and inadequate transport of drugs to the brain, resulting in limited effectiveness. The CNS homeostasis is maintained by various barriers within the brain, such as the endothelial, epithelial, mesothelial, and glial barriers, which strictly control the movement of chemicals, solutes, and immune cells. Brain capillaries consist of endothelial cells (ECs) and perivascular pericytes, with pericytes playing a crucial role in maintaining the blood-brain barrier (BBB), influencing new blood vessel formation, and exhibiting secretory capabilities. This article summarizes the structural components and anatomical characteristics of the BBB. Intranasal administration, a non-invasive method, allows drugs to reach the brain by bypassing the BBB, while direct cerebral administration targets specific brain regions with high concentrations of therapeutic drugs. Technical and mechanical tools now exist to bypass the BBB, enabling the development of more potent and safer medications for neurological disorders. This review also covers clinical trials, formulations, challenges, and patents for a comprehensive perspective. © 2024 Elsevier B.V.
Other Related Docs
11. Interplay Between Angiogenesis and Neurogenesis in Nerve Regeneration, Biomaterials for Vasculogenesis and Angiogenesis (2022)
14. Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders, Frontiers in Bioengineering and Biotechnology (2020)
15. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
18. Encapsulation: Controlled Drug Delivery, Principles of Biomaterials Encapsulation: Volume 2 (2023)
20. Bioavailability, Biodistribution, and Toxicity of Fluorescent Metal Nanoclusters, Luminescent Metal Nanoclusters: Synthesis# Characterization# and Applications (2022)
21. Nanotechnology-Based Theranostic Approaches in Brain Diseases, Theranostics Nanomaterials in Drug Delivery (2024)
24. The Effect of Insomnia on Development of Alzheimer's Disease, Journal of Neuroinflammation (2020)
30. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)
35. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)